Immuno-Oncology: Unlocking the Potential of our own Immune System

  • 09 Jan 2018
  • 5:00 PM - 7:30 PM
  • Fashion Institute of Design and Merchandising; 55 Stockton Street, San Francisco, CA 94108
Immunotherapy has revolutionized cancer treatment. With the accomplishment of First-in-Human trials, a steady increase in new candidate drug approvals, and a substantial pipeline of drugs in clinical and preclinical testing, modulation of the immune system has become a clinical reality. Yet, many open research questions need to be addressed before immune targeting will become routine therapy. This panel will discuss the promise of cancer immunotherapy, challenges, and rational design approaches for delivering therapeutics to maximize the impact of this powerful treatment.


REGISTER


Featuring:

Michael Aberman, '93

President and CEO, Quentis Therapeutics, Inc.


Lance Collins

Joseph Silbert Dean of Engineering


Marjolein van der Meulen

James M. and Marsha McCormick Director of Biomedical Engineering, Swanson Professor of Biomedical Engineering


Ankur Singh

Assistant Professor, Sibley School of Mechanical and Aerospace Engineering and the Meinig School of Biomedical Engineering


Program:
5:00PM Doors open

5:30PM Panel discussion

6:30PM Networking reception

7:30PM Program concludes


Location:
Fashion Institute of Design and Merchandising

55 Stockton Street

San Francisco, CA 94108


Parking:
Parking is available at the Ellis-O'Farrell Garage located at 123 O'Farrell Street. You can access the garage from O'Farrell Street or Ellis Street. Cornell University does not validate parking.


Cost:
$25 General Admission

$15 Young Alumni (Classes of 2008 - 2017)

Seats are going quickly; register today.


Questions:
Event Information: Contact Nancy Abrams Dreier

Registration: Contact Stephanie Watt


REGISTER

Copyright © 2018 Cornell NorCal - All rights reserved

Privacy Policy

Support